|
Post by imz72 on Oct 16, 2020 15:02:44 GMT
Register free for AIRM Virtual Building Dedication: ____________________________________________________ Date: October 21, 2020 Time: 2:00 pm - 2:45 pm EDT Venue: Online Website: www.eventbrite.com/e/airm-virtual-building-dedication-tickets-120427446735Join Astellas as we introduce our state-of-the-art research and manufacturing regenerative medicine facility in Westborough, MA.
The Astellas team in Massachusetts invites you to join us for a Virtual Event hosted by Astellas Institute for Regenerative Medicine Hear about the latest innovation in regenerative medicine as we introduce our state-of-the-art research and manufacturing regenerative medicine facility. Our virtual event will include remarks from: - The Honorable Karyn Polito, Lieutenant Governor of the Commonwealth of Massachusetts - Kenji Yasukawa, President & CEO, Astellas - Dr. Robert Langer, David H. Koch Institute Professor at MIT - Dr. Robert Lanza, Head of Astellas Global Regenerative Medicine, Chief Scientific Officer, Astellas Institute for Regenerative Medicine - Robert Coughlin, President & CEO, Massachusetts Biotechnology Council - The AIRM Leadership Team A traditional Japanese sake ceremony will conclude the dedication.
|
|
|
Post by JHam on Oct 19, 2020 15:29:16 GMT
Register free for AIRM Virtual Building Dedication: ____________________________________________________ Date: October 21, 2020 Time: 2:00 pm - 2:45 pm EDT Venue: Online Website: www.eventbrite.com/e/airm-virtual-building-dedication-tickets-120427446735Join Astellas as we introduce our state-of-the-art research and manufacturing regenerative medicine facility in Westborough, MA.
The Astellas team in Massachusetts invites you to join us for a Virtual Event hosted by Astellas Institute for Regenerative Medicine Hear about the latest innovation in regenerative medicine as we introduce our state-of-the-art research and manufacturing regenerative medicine facility. Our virtual event will include remarks from: - The Honorable Karyn Polito, Lieutenant Governor of the Commonwealth of Massachusetts - Kenji Yasukawa, President & CEO, Astellas - Dr. Robert Langer, David H. Koch Institute Professor at MIT - Dr. Robert Lanza, Head of Astellas Global Regenerative Medicine, Chief Scientific Officer, Astellas Institute for Regenerative Medicine - Robert Coughlin, President & CEO, Massachusetts Biotechnology Council - The AIRM Leadership Team A traditional Japanese sake ceremony will conclude the dedication. View AttachmentSake ceremony? Maybe I should check it out
|
|
|
Post by imz72 on Oct 21, 2020 19:23:23 GMT
Some pictures from the event: Karyn Polito, Lieutenant Governor of the Commonwealth of Massachusetts Robert Coughlin, President & CEO, Massachusetts Biotechnology Council Dr. Robert Lanza, Head of Astellas Global Regenerative Medicine, Chief Scientific Officer, Astellas Institute for Regenerative Medicine
|
|
|
Post by imz72 on Oct 21, 2020 19:26:51 GMT
Traditional Japanese sake ceremony
|
|
|
Post by imz72 on Oct 21, 2020 19:47:12 GMT
Dr. Lanza's speech (improvised audio only recording made by me): clyp.it/wvql0lve
|
|
|
Post by imz72 on Oct 23, 2020 10:23:10 GMT
The Astellas Institute for Regenerative Medicine Officially Opens in Massachusetts
10/22/20 The Astellas Institute for Regenerative Medicine (AIRM), a subsidiary of Astellas, has officially opened its state-of-the-art center for the research and development of regenerative medicine and cell therapy located in Westborough, Massachusetts. A virtual dedication of the new AIRM facility took place yesterday, including dignitaries Massachusetts Lt. Governor Karyn Polito; Robert Langer, ScD, David H. Koch Institute Professor at the Massachusetts Institute of Technology; Robert Coughlin, President & CEO of the Massachusetts Biotechnology Council. The new $120-million regenerative medicine facility is 262,000 square feet and enables capabilities across the full continuum from stem cell culturing, translational science, process development, drug development and GMP manufacturing. Approximately 180 employees currently work at the facility.The new AIRM facility is designed with the consideration of future progress of cell therapy development to enable Astellas to meet the demands of commercial production. The facility has seven GMP clean rooms compliant with global requirements from regulators that include the FDA, the European Medicines Agency, and Japan’s Pharmaceuticals and Medical Devices Agency. The Westborough site will encompass manufacturing of clinical trial material, or CTM, for commercialization of cell therapies. “From the beginning of planning this facility, our vision started with patients. We saw the opportunity to advance one of the most exciting classes of medicines, cell therapies, to treat diseases in an entirely new way to change the lives of patients,” said Yoshitsugu Shitaka, President of the Astellas Institute for Regenerative Medicine. “Astellas has made a global commitment to Blindness and Regeneration as one of the primary focus areas for our company. We are making investments and bringing the best science and the best people from all over the world that come here together at the Astellas Institute for Regenerative Medicine.” Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. For more information about the Astellas Biomedical Innovation Hub, please visit www.astellas.com/en/science/innovation-hub. citybizlist.com/article/635004/the-astellas-institute-for-regenerative-medicine-officially-opens-in-massachusetts
|
|
|
Post by JHam on Oct 23, 2020 14:05:53 GMT
The Astellas Institute for Regenerative Medicine Officially Opens in Massachusetts
10/22/20 The Astellas Institute for Regenerative Medicine (AIRM), a subsidiary of Astellas, has officially opened its state-of-the-art center for the research and development of regenerative medicine and cell therapy located in Westborough, Massachusetts. A virtual dedication of the new AIRM facility took place yesterday, including dignitaries Massachusetts Lt. Governor Karyn Polito; Robert Langer, ScD, David H. Koch Institute Professor at the Massachusetts Institute of Technology; Robert Coughlin, President & CEO of the Massachusetts Biotechnology Council. The new $120-million regenerative medicine facility is 262,000 square feet and enables capabilities across the full continuum from stem cell culturing, translational science, process development, drug development and GMP manufacturing. Approximately 180 employees currently work at the facility.The new AIRM facility is designed with the consideration of future progress of cell therapy development to enable Astellas to meet the demands of commercial production. The facility has seven GMP clean rooms compliant with global requirements from regulators that include the FDA, the European Medicines Agency, and Japan’s Pharmaceuticals and Medical Devices Agency. The Westborough site will encompass manufacturing of clinical trial material, or CTM, for commercialization of cell therapies. “From the beginning of planning this facility, our vision started with patients. We saw the opportunity to advance one of the most exciting classes of medicines, cell therapies, to treat diseases in an entirely new way to change the lives of patients,” said Yoshitsugu Shitaka, President of the Astellas Institute for Regenerative Medicine. “Astellas has made a global commitment to Blindness and Regeneration as one of the primary focus areas for our company. We are making investments and bringing the best science and the best people from all over the world that come here together at the Astellas Institute for Regenerative Medicine.” Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. For more information about the Astellas Biomedical Innovation Hub, please visit www.astellas.com/en/science/innovation-hub. citybizlist.com/article/635004/the-astellas-institute-for-regenerative-medicine-officially-opens-in-massachusetts Wow. Lanza has come a long way since Two Moons Kachinas.
|
|
|
Post by selluwud on Nov 17, 2020 14:12:16 GMT
|
|
|
Post by imz72 on Nov 17, 2020 15:19:30 GMT
A video of the event. The Lanza part is at 48:36 - 53:16:
|
|